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SUMMARY
COUNT: 249
BACKGROUND: Suboptimal antibiotic treatment of urinary tract infection (UTI) is high in long-term care
facilities (LTCFs) and likely varies between facilities, but large-scale evaluations have not been conducted.
AIM: To identify facility-level predictors of potentially suboptimal treatment of UTI in Veterans Affairs (VA)
LTCFs and to quantify variation across facilities.
METHODS: We conducted a retrospective cohort study in 21,938 residents of 120 VA LTCFs (2013-2018)
known as Community Living Centers (CLCs). Potentially suboptimal treatment was assessed from drug choice,
dose frequency, and/or treatment duration. To identify facility characteristics predictive of suboptimal UTI
treatment, we compared LTCFs with higher and lower rates of suboptimal treatment (>median, <median) using
unconditional logistic regression models. Joinpoint regression models were used to quantify the average
percent difference across facilities. Multilevel logistic regression models were used to quantify variation across
facilities.
FINDINGS: The rate of potentially suboptimal antibiotic treatment varied from 1.7 -34.2 per 10,000 bed days
across LTCFs. The average percent difference in rates across facilities was 2.5% (95% confidence interval [CI]
2.4%-2.7%). The only facility characteristic predictive of suboptimal treatment was the incident rate of UTI per
10,000 bed days (odds ratio 4.9, 95% CI 2.3-10.3). Multilevel models demonstrated that 94% of the variation
in potentially suboptimal treatment between facilities was unexplained after controlling for resident and CLC
characteristics.
CONCLUSION: Potentially suboptimal UTI treatment was variable across VA LTCFs. However, most of the
variation across LTCFs was unexplained. Future research should continue to investigate factors that are
driving suboptimal antibiotic treatment in LTCFs.
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TEXT
COUNT: 3,230
INTRODUCTION
Antibiotic stewardship, or coordinated interventions to improve and measure the appropriate use of antibiotics,
is increasingly being required in all healthcare settings, including long-term care facilities (LTCFs).1-4 There are
several recommendations available for approaches to antibiotic stewardship, however unfortunately there is no
“one-size fits all” approach and it remains a challenge for many facilities to implement successful antibiotic
stewardship strategies, such as educational materials or meetings and treatment guidelines.1, 2, 5-7 Challenges
for LTCFs include limited resources as compared to acute care facilities, and providers who are often off-site
and have to split their time between multiple facilities.7, 8 Tailored approaches to antibiotic stewardship might be
needed as the decision-making process surrounding antibiotic use is complex and varies widely between
facilities due to many factors such as facility size and type, resources available, staffing characteristics,
resident populations, and local antibiograms.6 Previous work has found that antibiotic use is highly variable
across LTCFs as are the antibiotic stewardship strategies used.9, 10 Inappropriate antibiotic treatment also likely
varies across facilities, but large-scale evaluations have not yet been conducted.

Quantification of the variation in inappropriate antibiotic treatment across facilities could be helpful in identifying
which facilities could benefit from additional antibiotic stewardship education or activities and in identifying
facility characteristics associated with higher rates of inappropriate antibiotic treatment. This information could
be helpful in developing tailored interventions for facilities to improve their antibiotic use. In LTCFs, suspected
urinary tract infections (UTIs) are the leading driver of overall antibiotic use, including inappropriate antibiotic
use.11-14 As such, we sought to evaluate the variation in suboptimal treatment of UTIs across VA long-term
care units (known as Community Living centers or CLCs). We did not assess whether the antibiotic treatment
residents received was necessary or not, but rather whether the antibiotic treatment received was suboptimal
with regards to antibiotic drug choice, dose frequency, and duration. The objectives of our work were to
describe the facility-level rate of potentially suboptimal treatment of residents with UTI, identify facility
characteristics predictive of suboptimal treatment, and to quantify the extent of variation across CLC facilities.
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METHODS
Study population.
We used a cohort of residents with a suspected incident UTI treated in a VA CLC between 2013-2018. We
have previously described methods used to identify our national VA study population.15, 16 Briefly, suspected
UTIs required collection of a urine culture and an antibiotic given on the culture collection date or within 3 days
after culture collection.15, 16 Our definition of UTI was based on guidelines of the Infectious Diseases Society of
America (IDSA) guidelines which require bacteriuria and symptoms for a UTI diagnosis.17, 18 An incident UTI
was defined as the first UTI per resident identified during the study period with no UTIs treated in a VA CLC in
the year prior. We excluded female residents of childbearing age and residents with a urologic procedure
within 2 weeks of the index date in order to exclude residents potentially treated appropriately for
asymptomatic bacteriuria.16, 18 Additionally, we excluded residents with other positive cultures from other nonurine sources to exclude those treated for another potential infection. We also excluded residents treated with
antibiotics over 30 days and those treated with any non-UTI or uncommon antibiotics.16

Exposure to potentially suboptimal antibiotic treatment.
Individual-Level Resident Exposure
We assessed exposure to potentially suboptimal antibiotic treatment at the individual resident level. We have
previously defined potentially suboptimal antibiotic treatment and subtypes of potentially suboptimal antibiotic
treatment. 16 Briefly, potentially suboptimal antibiotic treatment was defined as use of a suboptimal 1) initial
antibiotic drug choice 2) dose frequency, and/or 3) excessive treatment duration. Initial antibiotic drug choice
was suboptimal if resistance to the antibiotics used was detected from urine culture and susceptibility (C&S)
results in the prior 180 days.19 If there were no 180-day urine C&S results, initial antibiotic drug choice was
suboptimal if antibiotics used provided insufficient coverage (percent susceptibility <80% ) based on the local
CLC urine antibiogram from the year prior.19 Dose frequency was suboptimal if it did not agree with
recommendations for dosing based on renal function.12 Duration of therapy greater than 14 days was
suboptimal.20, 21
Aggregate Facility-Level CLC Exposure
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We assigned and aggregated individual residents to the single CLC where the first urine culture during UTI
treatment was obtained. We summarized initial treatment choice and rate of antibiotic use in days of therapy
per 10,000 bed days (DOT/10,000 bed days) by antibiotic class. We also summarized the rate of residents
receiving potentially suboptimal antibiotic treatment per 10,000 bed days across CLCs. We ranked CLCs by
this rate from those with the lowest rates to those with the highest rates. We then grouped CLCs into
suboptimal (those with rates at or above the median) and optimal CLCs (those with rates below the median). In
sensitivity analyses, we used unique residents as the denominator and summarized and ranked CLCs based
on the frequency of residents receiving potentially suboptimal treatment.

Potential independent predictors of potentially suboptimal antibiotic use.
Potential independent predictors of potentially suboptimal antibiotic treatment were selected a priori based on
clinical relevance and/or previous work.22-27 In previous work, we identified several resident characteristics that
were predictive of potentially suboptimal antibiotic treatment at the individual resident level.16 In this current
study, we assessed and identified CLC characteristics predictive of potentially suboptimal antibiotic treatment
at the aggregate CLC facility-level. We aggregated individual residents to the facility-level to determine
average demographic characteristics, such as average age, and CLC rate of incident UTIs per 10,000 bed
days. We considered CLC size (average daily census of more than 100 or not).28 We assessed location
(defined as urban or rural), geographic region (defined as Midwest, South, West, or Northeast), and proximity
of the CLC to a main VA medical center (VAMC) campus (defined as similar campuses, distinct campuses, or
other/unknown) as potentially predictors. We also considered several staffing and quality measures available
from the VA Strategic Analytics for Improvement Learning Model (SAIL) and the VA CLC Compare data. 29, 30
SAIL staffing measures are based on the average number of hours of care provided to each resident per day
by nursing staff (including registered nurses, licensed partitional nurses/ vocational nurses, and nurses aids).31
Quality measures used were developed from the Minimum Data Set (MDS) and Medicare claims data. 31
Quality measures assess health status, physical functioning, mental status, general well-being and other
information about the physical and clinical needs of the resident.31 Nursing homes are provided an overall 5
star quality rating, where nursing homes with a 5 star rating are considered much above average and those
with a 1 star rating are considered much below average.32
5

Analytic approach.
We described the CLC rate of potentially suboptimal antibiotic treatment (as defined above). We also
described the CLC rate of use of subtypes of potentially suboptimal antibiotic drug choice, dose frequency, and
excessive duration. We graphically displayed the distribution of facility-level aggregate rates across all CLCs.
Joinpoint regression models were used quantify the average percent difference across CLCs. Differences in
CLC characteristics between groups (suboptimal vs. optimal CLCs) were analyzed using chi-square or Fisher’s
exact tests for categorical data and Student’s t test or the Wilcoxon rank sum test for continuous data, as
appropriate. We identified CLC characteristics predictive of potentially suboptimal antibiotic treatment using
backwards, manual, stepwise unconditional logistic regression models.33 In univariate analysis, we identified
variables with a p-value of <0.10 and included these variables in subsequent multivariable analysis. Next we
removed variables one at a time from the multivariable model until variables in the final model demonstrated
statistical significance (p-value <0.05).33

We built three multilevel logistic regression models with random intercepts for each CLC to examine variation
in potentially suboptimal antibiotic treatment among residents with UTIs across CLCs. Two level random
intercept models were estimated among individual residents with UTIs (level 1) nested within CLCs (level 2). In
these models the probability of potentially suboptimal antibiotic treatment was allowed to vary across CLCs but
the effect of resident characteristics was fixed for all CLCs.34 The null model was the empty model which only
incorporated CLC-specific random intercepts and did not contain any resident or CLC characteristics. The first
model included resident characteristics identified as independent predictors of potentially suboptimal antibiotic
treatment (identified from our previous work) and CLC-specific random intercepts. 16 Resident-level predictors
that were potentially correlated with the random effects were removed from the multilevel models, as the
random effects are assumed to be independent of the model covariates.35 The second model included CLC
characteristics identified as independent predictors of potentially suboptimal antibiotic treatment (from our
predictive analyses) and CLC-specific random intercepts. The third model included both resident
characteristics and CLC characteristics identified as independent predictors and CLC-specific random
intercepts. We included year as a fixed effect in all three models.
6

We calculated the intraclass correlation coefficient (ICC) to measure components of variance. To calculate the
ICC, we used the latent variable approach which assumes that the dichotomous dependent variable comes
from an unknown latent continuous variable with a residual that follows a logistic distribution with a mean of 0
and a variance of 3.29.36 We determined the percentages of additional variance explained by comparing each
model to the null model.34, 37 We calculated the median odds ratio (MOR) to quantify the heterogeneity
between CLCs.35, 38 We preformed analyses with SAS versions 9.2 and 9.4 and Joinpoint Regression Program
version 4.6.0.0.

RESULTS
Between 2013-2018, 21,938 residents with an incident UTI were treated in 120 VA CLCs. The median average
daily census of CLCs ranged from 5-248 (median 67). The average percentage of residents that were male in
each CLC was 95.9% and the median average age of residents was 75.2 years. The rate of incident UTI
ranged from 2.9-51.3 per 10,000 bed days (median 10.3 per 10,000 bed days) across CLCs. The total rate of
incident UTI antibiotic use ranged from 21.7-578.2 DOT per 10,000 bed days across CLCs (median 92.6 DOT/
per 10,000 bed days, supplemental Figure 1), The CLCs at the minimum and maximum used fluoroquinolones
as initial treatment in 5.2% and 54.2% of residents with incident UTIs, respectively (median 34.3%,
supplemental Figure 2).

In Figure 1, the rate of residents receiving potentially suboptimal antibiotic treatment and subtypes of
potentially suboptimal antibiotic treatment per 10,000 bed days are presented across VA CLCs and ranked
from CLCs with the lowest to highest rates. In the CLC at the median, the rate was 6.8 per 10,000 bed

days. In the CLC at the minimum, the rate of potentially suboptimal antibiotic treatment was 1.7 per 10,000
bed days. In the CLC at the maximum, the rate was 34.2 per 10,000 bed days. The average percent difference
in rates from lowest to highest CLC was 2.5% (95% confidence interval [CI] 2.4%-2.7%), Figure 2. The rate of
potentially suboptimal initial drug choice ranged from 1.2-27.2 per 10,000 bed days (median 4.7 per 10,000
bed days), potentially suboptimal dose frequency ranged from 0.8-22.5 per 10,000 bed days (median 2.8 per
10,000 bed days), and excessive duration ranged from 0.2-10.4 per 10,000 bed days (median 1.3 per 10,000
7

bed days) for the CLCs at the minimum and maximum, respectively. Similar results were observed when
assessing frequency of potentially suboptimal treatment and subtypes of potentially suboptimal treatment
(supplemental Table I and Figure 1).

Table I presents a comparison of CLC characteristics for suboptimal (those with rates of potentially suboptimal
antibiotic treatment at or above the median, > 6.8 per 10,000 bed days) vs optimal CLCs (those with rates
below the median, < 6.8 per 10,000 bed days). Suboptimal CLCs were more likely to have higher incident
UTI rates (median incident UTI rate [interquartile range]: 15.9 [12.4–19.2] vs. 7.6 [6.3–8.9] per 10,000 bed
days, p<0.001). The only CLC characteristic predictive of higher suboptimal antibiotic treatment was the
incident UTI rate. The odds of being a CLC with higher rates of potentially suboptimal antibiotic treatment
increased by 4.9 times (95% CI 2.3-10.3) with each unit increase in the incident UTI rate. No CLC
characteristics were identified as independent predictors of higher suboptimal antibiotic treatment in
multivariable sensitivity analyses (supplemental Table II).

The null multilevel model demonstrated that the between CLC variation in potentially suboptimal antibiotic
treatment was 3.42% (Table II). Together resident characteristics and CLC characteristics reduced the CLClevel variance by 0.20%, and thereby explained 5.98% of the observed CLC-level variance in potentially
suboptimal antibiotic treatment. The median odds ratio for the full model was 1.37.

DISCUSSION
Our study is the first to demonstrate significant variation in potentially suboptimal antibiotic treatment of
incident UTIs across a large nationwide group of LTCFs.

Our results are supported by previous studies which have consistently found variation in antibiotic usage
among LTCFs.9, 10, 39-41 Among 73 nursing homes in 4 US states, mean facility antibiotic use ranged from 0.423.5 courses per 1,000 resident days.9 Among 607 nursing homes in Canada, antibiotic use ranged from 20.4192.9 antibiotic-days per 1,000 resident-days.10 In these prior studies, UTI was generally among the most
common conditions for which antibiotics were prescribed.9, 41 While prior studies did not assess antibiotic
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appropriateness or focus specifically on the treatment of UTIs, it is reasonable to expect that the inter-facility
variations in antibiotic use observed may have been related at least in part to variations in the appropriate use
of antibiotics for UTI.

Another key finding of our study was that the only CLC characteristic that was predictive of higher rates of
potentially suboptimal antibiotic treatment was incident UTI rate. Thus, it may be important to focus antibiotic
stewardship strategies in CLCs with higher incidence UTI rates. Example strategies that may be helpful include
implementation of facility-specific antibiotic guides and/or educational sessions and materials with specific
recommendations to optimize drug choice, dose, and duration for residents with UTI based on national
guidelines and local urinary antibiograms.42, 43 A cluster randomized trial among 8 public LTCFs in Canada
found that mailing an antibiotic guide to physicians was associated with a 20.5% reduction in inappropriate
antibiotic prescriptions in intervention facilities as compared to a reduction of only 5.1% in the control
facilities.42 The antibiotic guide was targeted to common infections, including UTI, and had recommendations
for empiric treatment including recommendations for antibiotic choice, dose, frequency, and duration.
Disseminating treatment guidelines with education to facilities could reduce heterogeneity and may represent
an easy approach to improve the treatment of UTI across VA CLCs.42, 43 Development of “peer comparison”
tools that display the interfacility variation in potentially suboptimal antibiotic treatment may also decrease
variability across facilities.44 By seeing a visual display of interfacility variation in potentially suboptimal
antibiotic treatment, LTCFs could see where they rank compared to other facilities and use this information to
improve antibiotic use at their facility.45 As misdiagnosis and unnecessary treatment of UTI is another wellknown problem in LTCFs, antibiotic stewardship strategies should address both suboptimal and unnecessary
UTI treatment.12, 14

We also found that a large amount of the variation in potentially suboptimal antibiotic treatment remained
unexplained even after adjusting for resident and CLC characteristics, and thus there may be other factors
driving the variation. There is a great need to continue to investigate factors, to explain the variation in
potentially suboptimal antibiotic treatment across LTCFs. Several potentially important measures of CLC
performance were not included in our retrospective analysis, such as nurse staffing levels, admission rates into
9

the CLC vs. long stay prevalence, hospitalization rates, and whether CLC attendings also attended in acute
care settings, since these are not readily measured. There also may be other factors that are not typically
available in large electronics datasets which were not included, such as knowledge and practice of health care
professionals, the context of the facility including the complexity of the resident population and access to
doctors and diagnostic tests, and the social interaction between nurses, residents' families and doctors.46
Other factors that might drive variations observed include differences in resident and family expectations, the
use of antibiotics near the end of life, and the medical and nursing staff caring for residents life.47 Physician
preferences, which refers to prescribing practices that are based on non-clinical factors such as time of the
day, staff biases, or fear or liability concerns, may also account for some of the some of the unexplained
variation we observed.48

Our findings may also support the need for tailored interventions in each CLC since the driving factors of
potentially suboptimal treatment might vary by CLC .6 Additionally the median odds ratio for the full model was
1.37 which suggests that between two identical residents with UTIs (with the same covariate patterns) treated
at two randomly chosen CLCs, in one of the residents potentially suboptimal antibiotic treatment would be 37%
more likely than in the other resident just because of the CLC in which the resident was treated. This suggests
the need for facilities to focus on targeted interventions based on characteristics that may be unique to each
facility. Therefore, while individual CLC site visits are time consuming and labor intensive, they may be helpful
in determining which factors might be driving potentially suboptimal UTI treatment at each CLC.

There are limitations to this study. First, despite considering a large set of potential predictors, approximately
94% of the variation in use of potentially suboptimal antibiotics remained unexplained. As such, there
likelywere other important unmeasured characteristics. There could have also been measurement error in the
included characteristics. We were not able to capture the presence/extent of existing antibiotic stewardship
services in place at each facility which may explain some of the variation. Comprehensive surveys of the
antibiotic stewardship strategies at each CLC are warranted to investigate the impact of these factors in future
work. Second, we only captured residents with a suspected UTI in which a urine culture was collected and was
treated with antibiotics in a VA CLC. We thus did not capture residents in whom a urine sample was not
10

collected or available such as those with poor urine output, or urinary incontinence. Third, there are no
established definitions for suboptimal antibiotic treatment of residents with UTI and as such our definitions
were based on best available guidelines and expert opinion. In clinical practice determining the most optimal
treatment is complex and based on a number of factors such as previous allergies and adverse drug events,
comorbidities, and concomitant medications. Thus, despite meeting our definition for potentially suboptimal
treatment, the antibiotics used may have represented the most optimal treatment for the resident. Moreover,
there is no established definitions for high suboptimal antibiotic treatment rates at the facility-level, which is
why we utilized the median level. Fourth, we did not assess prescriber or provider characteristics which may
influence potentially suboptimal antibiotic use, such as provider type, specialty, knowledge or previous
experience. Fifth, the generalizability of findings to non-VA LTCF populations may be limited, as the CLC
populations generally include more males and residents with more complex medical needs than community
LTCFs. Moreover, each VA CLC is part of the nation’s largest integrated healthcare system, and findings may
not be generalizable to stand alone community LTCFs with more limited resources.

CONCLUSIONS
In this large national study of almost 22,000 residents with an incident UTI treated in 120 VA CLCs, potentially
suboptimal antibiotic treatment was highly variable across CLCs. The only CLC characteristic of predictive of
suboptimal antibiotic use was the incident UTI rate. Despite findings, most of the variation across CLCs
remained unexplained. Future research should continue to investigate factors that are predictive of suboptimal
antibiotic treatment.
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Table I. Comparison of CLC characteristics between suboptimal and optimal CLCs
CLC Characteristic

Suboptimal CLCs (those with rates of

Optimal CLCs (those with rates of

P

potentially suboptimal antibiotic treatment at

potentially suboptimal antibiotic treatment

value

or above the median, > 6.8 per 10,000 bed

below the median, < 6.8 per 10,000 bed

days, n =60)

days, n =60)

Median Average Resident Age (IQR)

75.0 (73.2-76.5)

75.5 (74.2-77.1)

0.103

Average percent male, (+/- SD)

95.7% (2.3%)

96.1% (2.1%)

0.268

Average percent white, (+/- SD)

77.5% (15.6%)

73.8% (17.3%)

0.237

Average percent Hispanic, (+/- SD)

4.4% (12.8%)

2.7% (4.2%)

0.710

Average percent married, (+/- SD)

41.4% (7.3%)

42.3% (8.9%)

0.548

15.9 (12.4-19.2)

7.6 (6.3-8.9)

<0.001

Incident UTI rate per 10,000 bed
days, median (IQR)
Region, n(%)

0.074

South

18 (30.0)

20 (33.3)

Midwest

20 (33.3)

11 (18.3)

Northeast

8 (13.3)

18 (30.0)

West

14 (23.3)

11 (18.3)

Proximity to acute care facility, n(%)
Same campus

0.40
43 (71.7)

37 (61.7)
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Remote

10 (16.7)

16 (26.7)

Other

7 (11.7)

7 (11.7)

10 (16.7)

10 (16.7)

1.0

8 (13.3)

21 (35)

<0.001

3.2 (2.5 - 4.0)

2.3 (1.9 - 3.3)

<0.001

1.7 (1.2 - 2.4)

1.5 (0.9 - 2.0)

0.068

3.0 (2.4 - 4.0)

3.3 (2.7 - 3.8)

0.285

8.1 (7.0 - 9.6)

7.4 (6.2 - 8.6)

0.008

Overall star rating median (IQR)

4.0 (3.0 - 5.0)

4.0 (3.0.- 5.0)

0.447

Survey rating, median (IQR)

4.0 (2.0 - 4.0)

3.0 (2.0 - 4.0)

0.078

Staffing rating, median (IQR)

5.0 (5.0 - 5.0)

5.0 (5.0 - 5.0)

1.0

Quality rating, median (IQR)

3.0 (2.0 - 4.0)

4.0 (3.0 - 5.0)

0.02

Rural campus, n(%)
Average daily census size greater
than 100, n(%)*
Staffing**
RN hours per resident day, median
(IQR)
LPN hours per resident day,
median (IQR)
Nurse aide hours per resident day,
median (IQR)
Total nurse staff hours per resident
day, median (IQR)
Quality Ratings***

Quality Measures*****
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Percentage of short stay residents
with a newly received antipsychotic
medication, median (IQR)*

2.1 (1.2 - 3.3)

1.3 (0.7 - 2.4)

0.013

27.8 (19.2 - 39.0)

23.6 (16.9 - 32.5)

0.074

0.5 (0 - 1.2)

0.4 (0.0 - 1.1)

0.91

72.9 (65.7 - 78.0)

68.9 (57.6 - 76.6)

0.077

9.2 (5.1 - 13.7)

7.1 (4.5 - 10.0)

0.084

2.2 (0.7 - 3.6)

2.1 (1.0 - 3.7)

0.704

Percentage of short stay residents
with moderate or severe pain,
median (IQR)*
Percentage of short stay residents
with a new or worse pressure ulcer,
median (IQR)*
Percentage of short stay residents
with improvement in function,
median (IQR)
Percentage of short stay residents
with a high-risk resident pressure
ulcer, median (IQR)
Percentage of long stay residents
with one or more falls with major
injury, median (IQR)
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Percentage of long stay residents
with a catheter left in bladder,
median (IQR)

2.4 (0.5 - 4.9)

2.0 (0.6 - 3.0)

0.299

13.7 (8.8 - 16.6)

15.0 (10.0 - 21.0)

0.210

34.5 (20.6 - 49.5)

30.4 (15.5 - 43.9)

0.096

13.7 (10.0 - 18.0)

13.0 (9.8 - 17.4)

0.379

2.3 (1.6 - 4.0)

2.1 (1.2 - 3.5)

0.222

13.0 (9.4 - 16.4)

11.7 (8.1 - 15.5)

0.605

Percentage of long stay residents
with a newly received antipsychotic
medication, median (IQR)
Percentage of long stay residents
with moderate or severe pain,
median (IQR)
Percentage of long stay residents
who need help in activities of daily
living, median (IQR)
Percentage of long stay residents
with a UTI, median (IQR)
Percentage of long stay residents
with ability to move independently,
median (IQR)

CLC= Community Living Center; IQR= Interquartile range; LPN= Licensed practical nurse; RN= Registered nurse; SD= Standard deviation; UTI=
Urinary tract infection; VA= Veterans Affairs
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Individual residents with UTIs were aggregated to the single CLC in which the first urine culture during the UTI treatment period was obtained. We
aggregated 21,938 individual residents with an incident UTI between 2013-2018 to 120 separate VA CLCs. We compared suboptimal and optimal
CLCs (rates of potentially suboptimal antibiotic treatment at the median or above; rates below the median).

*We defined CLC size based on average daily census from 2015-2018.

**Staffing measures are based on the average number of hours of care provided to each resident per day by nursing staff (including registered
nurses, licensed partitional nurses/ vocational nurses, and nurses aids)

***Quality ratings are based on health surveys, staffing, and quality of resident care measures. VA CLCs are given a rating between 1 and 5 stars
on each of these three domains and also assigned an overall star rating. 5 star ratings are considered much above average and 1 star ratings are
considered much below average.

**** Quality measures are assessed separately for short stay residents, those who spend 100 days or less in the nursing home) and long stay
residents (who spend more than 100 days in the nursing home.

20

Table II. Variance components and median odds ratios from multilevel logistic regression models
Variance at the CLC level Median odds ratio
Null model

3.42%

1.38

Model 1: Resident characteristics included

3.35%

1.38

Model 2: CLC characteristics included

3.24%

1.37

Model 3 (full model): Resident and CLC characteristics included 3.22%

1.37

CLC= Community Living Center; UTI= Urinary tract infection

Table 2 presents components of variance in potentially suboptimal antibiotic treatment attributed to the CLC-level. The null model variance
component indicates that approximately 3.42% of the variability in the underlying propensity for potentially suboptimal antibiotic treatment of
residents with incident UTIs is accounted for by the CLCs, leaving 96.58% of the variability to be accounted for by the systematic differences
between the individual residents.
The null model was the empty model which only included random intercepts for each CLC.
Model 1 included random intercepts for each CLC and adjusted for resident characteristics (cardiopulmonary comorbidity, renal disease
comorbidity, genitourinary disorder comorbidity, recent high white blood cell count, age, prior fluoroquinolone exposure, prior skin infection, prior
hospitalization) and year.
Models 2 included random intercepts for each CLC and adjusted for CLC characteristics (CLC rate of incident UTI) and year.
Models 3 included random intercepts for each CLC and adjusted for resident characteristics included in Model 1 and CLC characteristics included in
Model 2 and year.
Not presented in table, model which included random intercepts for each CLC and adjusted for year reduced the variance by 0.03 and explained
only 0.83% of the variance in potentially suboptimal antibiotic treatment.
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Figure 1. Ranking of 120 CLCs based on rate of residents receiving potentially suboptimal antibiotic treatment for suspected incident
UTIs and subtypes of potentially suboptimal antibiotic treatment
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Potentially suboptimal antibiotic dose frequency***

Potentially suboptimal antibiotic duration****
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Median rate of potentially suboptimal antibiotic treatment, facilites below this line have lower rates of potentially suboptimal antibiotic
treatment

Median rate of potentially suboptimal antibiotic treatment, facilites below this line have higher rates of potentially suboptimal antibiotic
treatment

Individual residents with UTIs were aggregated to the single CLC in which the first urine culture during the UTI treatment period was obtained. We
aggregated 21,938 individual residents with an incident UTI between 2013-2018 to 120 separate VA CLCs. The rate of residents receiving
potentially suboptimal antibiotic treatment and subtypes potentially suboptimal antibiotic treatment per 10,000 bed days are presented across VA
CLCs. VA CLCs were ranked from those with the lowest to highest rate of potentially suboptimal antibiotic treatment. VA facilities below the green
line are facilities with rates of potentially suboptimal antibiotic treatment below the median (CLCs with lower rates of potentially suboptimal antibiotic
treatment). VA facilities above the red line are facilities with rates of potentially suboptimal antibiotic treatment above the median (CLCs with higher
rates of potentially suboptimal antibiotic treatment).

*Potentially suboptimal antibiotic treatment was defined as exposure to any of subtype of potentially suboptimal antibiotic treatment (drug, dose
frequency dose frequency, and/or duration).
**Potentially suboptimal initial drug choice was defined based on previous urine cultures and susceptibilities or local CLC urine antibiogram. Initial
treatment was defined as antibiotics given on the first day of the UTI treatment period.
***Potentially suboptimal dose frequency was defined based on renal function.
****Potentially suboptimal antibiotic duration was defined as an excessive treatment duration greater than 14 days.
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Figure 2. Average percent difference in rate of residents receiving potentially suboptimal antibiotic treatment across CLCs from Joinpoint

Rate of potentially suboptimal antibiotic treatment
per 10,000 bed days

analyses

Facility rank
*Indicates that the Average Percent Change (APC) is significantly different from zero at the alpha of 0.05 level. Final model included 5 Joinpoints.
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Supplemental Table 1. Frequency of suboptimal antibiotic use and subtypes of suboptimal antibiotic
use across CLCs
Potentially

Potentially

Potentially

suboptimal

suboptimal

suboptimal

antibiotic drug

antibiotic dose

antibiotic

choice**

frequency***

duration****

Potentially
suboptimal
antibiotic use*

Minimum

36.8%

22.4%

13.6%

3.1%

Quartile 1

61.1%

36.9%

23.2%

9.4%

Median

66.3%

48.6%

28.2%

12.2%

Quartile 3

71.0%

54.7%

31.8%

15.4%

Maximum

100.0%

100.0%

47.5%

37.2%

Individual residents with UTIs were aggregated to the single CLC in which the first urine culture during the UTI
treatment period was obtained. We aggregated 21,938 individual residents with an incident UTI between
2013-2018 to 120 separate VA CLCs. The frequency of residents receiving potentially suboptimal antibiotic
treatment and subtypes potentially suboptimal antibiotic treatment (unique resident as the denominator) are
presented across VA CLCs.

*Potentially suboptimal antibiotic treatment was defined as exposure to any of subtype of potentially suboptimal
antibiotic treatment (drug, dose frequency dose frequency, and/or duration).
**Potentially suboptimal initial drug choice was defined based on previous urine cultures and susceptibilities or
local CLC urine antibiogram. Initial treatment was defined as antibiotics given on the first day of the UTI
treatment period.
***Potentially suboptimal dose frequency was defined based on renal function.
****Potentially suboptimal antibiotic duration was defined as an excessive treatment duration greater than 14
days.
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Supplemental Table 2. Comparison of CLC characteristics between suboptimal and optimal CLCs
CLC Characteristic

Median Resident Age (IQR)

Suboptimal CLCs (those with

Optimal CLCs (those with

P

frequencies of potentially

frequencies of potentially

value

suboptimal antibiotic

suboptimal antibiotic

treatment at or above the

treatment below the median,

median, n =60)

n =60)

75.4 (74.2-76.8)

75.0 (73.1-76.7)

0.187

96.1% (2.2%)

95.8% (2.2%)

0.438

75.1% (16.7%)

76.2% (16.5%)

0.713

4.2% (12.5%)

3.0% (5.1%)

0.484

42.1% (7.2%)

41.6% (9.0%)

0.765

9.0 (7.0-12.9)

11.9 (8.3-17.3)

0.014

Average percent male, (+/SD)
Average percent white, (+/SD)
Average percent Hispanic,
(+/- SD)
Average percent married, (+/SD)
Incident UTI rate per 10,000
bed days, median (IQR)
Region, n(%)

0.954

South

20 (33.3)

18 (30)

Midwest

16 (26.7)

15 (25)

Northeast

12 (20)

14 (23.3)

West

12 (20)

13 (21.7)

Proximity to acute care
facility, n(%)

0.846

Same campus

39 (65.0)

41 (68.3)

Remote

13 (21.7)

13 (21.7)

Other

8 (13.3)

6 (10)

13 (21.7)

7 (11.7)

Rural campus, n(%)

0.142
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Average daily census size
greater than 100, n(%)*

12 (20)

17 (28.3)

0.286

2.8 (2.0 - 3.8)

2.6 (2.1 - 3.7)

0.682

1.7 (1.1 - 2.3)

1.5 (1.1 - 2.0)

0.322

3.3 (2.5 - 3.9)

3.2 (2.7 - 4.0)

0.840

8.9 (6.5 - 9.2)

7.6 (6.6 - 8.9)

0.949

4.0 (3.0 - 5.0)

4.0 (3.0.- 5.0)

0.541

3.0 (2.0 - 4.0)

3.0 (2.0 - 4.0)

0.714

5.0 (5.0 - 5.0)

5.0 (5.0 - 5.0)

1.0

3.0 (2.0 - 4.5)

3.0 (3.0 - 4.0)

0.758

1.5 (0.9 - 2.4)

2.2 (1.0 - 4.0)

0.039

25.1 (18.5 - 37.5)

25.0 (16.0 - 38.0)

0.953

Staffing**
RN hours per resident day,
median (IQR)
LPN hours per resident day,
median (IQR)
Nurse aide hours per
resident day, median (IQR)
Total nurse staff hours per
resident day, median (IQR)
Quality Ratings***
Overall star rating median
(IQR)
Survey rating, median (IQR)
Staffing rating, median
(IQR)
Quality rating, median (IQR)
Quality Measures*****
Percentage of short stay
residents with a newly
received antipsychotic
medication, median (IQR)*
Percentage of short stay
residents with moderate or
severe pain, median (IQR)*
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Percentage of short stay
residents with a new or worse
pressure ulcer, median (IQR)*

0.3 (0 - 1.2)

0.5 (0.0 - 1.2)

0.89

71.7 (62.8 - 77.0)

71.1 (61.5 - 76.7)

0.823

8.3 (5.3 - 13.5)

7.1 (4.2 - 12.2)

0.162

2.2 (0.4 - 3.4)

2.1 (1.0 - 3.6)

0.833

2.2 (0.5 - 3.4)

2.2 (0.1 - 4.8)

0.914

14.4 (7.8 – 18.6)

13.9 (10.3 - 18.2)

0.612

32.1 (16.2 - 45.6)

31.9 (17.5 - 44.3)

0.876

13.6 (10.0 - 18.4)

13.0 (9.7 - 17.6)

0.503

Percentage of short stay
residents with improvement in
function, median (IQR)
Percentage of short stay
residents with a high-risk
resident pressure ulcer,
median (IQR)
Percentage of long stay
residents with one or more
falls with major injury, median
(IQR)
Percentage of long stay
residents with a catheter left
in bladder, median (IQR)
Percentage of long stay
residents with a newly
received antipsychotic
medication, median (IQR)
Percentage of long stay
residents with moderate or
severe pain, median (IQR)
Percentage of long stay
residents who need help in
activities of daily living,
median (IQR)
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Percentage of long stay
residents with a UTI, median
(IQR)

2.1 (1.1 - 3.7)

2.3 (1.6 - 3.6)

0.385

12.6 (9.6 - 16.4)

11.5 (7.2 - 16.2)

0.433

Percentage of long stay
residents with ability to move
independently, median (IQR)

CLC= Community Living Center; IQR= Interquartile range; LPN= Licensed practical nurse; RN= Registered
nurse; SD= Standard deviation; UTI= Urinary tract infection; VA= Veterans Affairs

In multivariable analysis, no CLC characteristics were identified as independent predictors of suboptimal UTI
treatment.

Individual residents with UTIs were aggregated to the single CLC in which the first urine culture during the UTI
treatment period was obtained. We aggregated 21,938 individual residents with an incident UTI between 20132018 to 120 separate VA CLCs. VA CLCs were ranked from those with the lowest to highest frequency of
potentially suboptimal antibiotic treatment. We compared suboptimal and optimal CLCs (defined as CLCs with
frequencies of potentially suboptimal antibiotic treatment at the median or above; and those with frequencies
below the median).

*We defined CLC size based on average daily census from 2015-2018.

**Staffing measures are based on the average number of hours of care provided to each resident per day by
nursing staff (including registered nurses, licensed partitional nurses/ vocational nurses, and nurses aids)

***Quality ratings are based on health surveys, staffing, and quality of resident care measures. VA CLCs are
given a rating between 1 and 5 stars on each of these three domains and also assigned an overall star rating.
5 star ratings are considered much above average and 1 star ratings are considered much below average.
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**** Quality measures are assessed separately for short stay residents, those who spend 100 days or less in
the nursing home) and long stay residents (who spend more than 100 days in the nursing home.
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Supplemental Figure 1. Rate of incident UTI antibiotic use by antibiotic class across VA CLCs

Fluoroquinolone
Min
Q1
Median
Q3
Max

5.6
20.6
27.5
42.9
153.2

GenitoAmino3rd/4th gen
1st/2nd gen
Carbapenem/ Antiurinary
penicillin
cephalosporin cephalosporin piperacillinAgen
tract agent
tazobactam
0.5
1.4
1.3
0.4
0.0
12.0
7.4
6.0
4.3
3.7
17.3
11.7
10.6
7.6
7.5
26.5
20.0
18.4
15.5
13.4
131.9
87.2
68.6
42.7
97.0

CLC= Community Living Center; Max= Maximum; Min= Minimum; MRSA= Methicllin-resistant
Staphylococcus aureus; Q1= Quartile 1; Q3=Quartile 3; UTI= Urinary Tract Infection; VA= Veterans’
Affairs
We identified suspected incident UTIs among residents in VA CLCs from 2013-2018. We aggregated individual
UTIs to the facility-level and summarized antibiotic use rates in days of therapy per 10,000 bed days by antibiotic
class.
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Supplemental Figure 2. Frequency of initial UTI treatment by antibiotic class across VA CLCs

GenitoAmino3rd/4th gen
1st/2nd gen
Carbapenem/ Anti-M
urinary
penicillin
cephalosporin cephalosporin piperacillinAgen
tract agent
tazobactam
Min
5.2%
0.0%
0.0%
0.0%
0.0%
0.0%
Q1
25.5%
13.1%
6.3%
4.8%
4.0%
1.9%
Median
34.3%
18.5%
9.4%
8.3%
6.6%
3.5%
Q3
40.5%
24.6%
13.5%
12.7%
11.2%
5.3%
Max
54.2%
51.4%
27.0%
30.6%
38.2%
27.1%
CLC= Community Living Center; Max= Maximum; Min= Minimum; MRSA= Methicllin-resistant
Staphylococcus aureus; Q1= Quartile 1; Q3=Quartile 3; UTI= Urinary Tract Infection; VA= Veterans’
Affairs
Fluoroquinolone

We identified suspected incident UTIs among residents in VA CLCs from 2013-2018. We aggregated individual
UTIs to the facility-level and summarized the frequency of initial treatment choice by antibiotic class.
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